sellModerate cluster of 610b5-1 plan
Tate Michael Truett sold $36M of ALAB
Chief Financial Officer at Astera Labs, Inc.. 334,000 shares at an average of $108.15, traded Dec 2, 2024, filed Dec 4, 2024.
Warning score
47Value
$36M
334,000 shares
Holdings after
1,428,888
-19% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001736297-24-000061, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -24,077 | $101.62 | $2.4M | 1,738,811 | Dec 4, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -55,003 | $102.59 | $5.6M | 1,683,808 | Dec 4, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -84,220 | $103.49 | $8.7M | 1,599,588 | Dec 4, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -3,700 | $104.44 | $386k | 1,595,888 | Dec 4, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -1,185 | $105.80 | $125k | 1,594,703 | Dec 4, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -1,600 | $107.08 | $171k | 1,593,103 | Dec 4, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -1,180 | $108.16 | $128k | 1,591,923 | Dec 4, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -4,575 | $109.58 | $501k | 1,587,348 | Dec 4, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -21,670 | $110.52 | $2.4M | 1,565,678 | Dec 4, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -19,793 | $111.32 | $2.2M | 1,545,885 | Dec 4, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -27,905 | $112.53 | $3.1M | 1,517,980 | Dec 4, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -18,489 | $113.54 | $2.1M | 1,499,491 | Dec 4, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -19,804 | $114.54 | $2.3M | 1,479,687 | Dec 4, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -25,978 | $115.71 | $3.0M | 1,453,709 | Dec 4, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -23,222 | $116.46 | $2.7M | 1,430,487 | Dec 4, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -1,599 | $117.10 | $187k | 1,428,888 | Dec 4, 2024 |
Related signals
Other insiders at Astera Labs, Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 25Weak | sell10b5-1 | ALAB Astera Labs, Inc. | Dyckerhoff Stefan A director | $4.7M | 12,499 | |
| 35Weak | sell 510b5-1 | ALAB Astera Labs, Inc. | ALBA MANUEL director | $1.3M | 11,000 | |
| 42Moderate | sell 510b5-1 | ALAB Astera Labs, Inc. | Tate Michael Truett Chief Financial Officer | $1.9M | 16,000 | |
| 45Moderate | sell 610b5-1 | ALAB Astera Labs, Inc. | ALBA MANUEL director | $14M | 126,000 | |
| 45Moderate | sell 710b5-1 | ALAB Astera Labs, Inc. | HURLSTON MICHAEL E. director | $6.7M | 67,453 | |
| 45Moderate | sell 710b5-1 | ALAB Astera Labs, Inc. | Mohan Jitendra Chief Executive Officer | $19M | 173,366 | |
| 60Notable | sell 7 | ALAB Astera Labs, Inc. | Dyckerhoff Stefan A director | $4.9M | 45,629 | |
| 45Moderate | sell 810b5-1 | ALAB Astera Labs, Inc. | Mohan Jitendra Chief Executive Officer | $18M | 171,064 | |
| 75Notable | sell 8 | ALAB Astera Labs, Inc. | Dyckerhoff Stefan A director | $18M | 203,445 | |
| 57Moderate | sell 8 | ALAB Astera Labs, Inc. | Tate Michael Truett Chief Financial Officer | $672k | 7,398 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.